Back to Search Start Over

Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study

Authors :
Kimber, Jo
Larney, Sarah
Hickman, Matthew
Randall, Deborah
Degenhardt, Louisa
Source :
The Lancet Psychiatry; October 2015, Vol. 2 Issue: 10 p901-908, 8p
Publication Year :
2015

Abstract

Opioid dependence increases risk of premature mortality. Opioid substitution therapy with methadone or buprenorphine reduces mortality risk, especially for drug-related overdose. Clinical guidelines recommend methadone as the first line of opioid substitution therapy. We aimed to test whether buprenorphine treatment has a lower mortality risk than does methadone treatment by comparing all-cause mortality and drug-related overdose mortality at treatment induction, after in-treatment medication switches, and following treatment cessation.

Details

Language :
English
ISSN :
22150366
Volume :
2
Issue :
10
Database :
Supplemental Index
Journal :
The Lancet Psychiatry
Publication Type :
Periodical
Accession number :
ejs36800297
Full Text :
https://doi.org/10.1016/S2215-0366(15)00366-1